Eli Lilly which makes Mounjaro released another tirzepatide medication called Zepbound, which was FDA-approved to treat weight loss in 2023
These effects make GLP-1 injections an effective option for weight loss, as they help control hunger, reduce cravings, and encourage healthier eating habits
NAD+ IV therapy is a legitimate metabolic intervention with credible biological rationale, preliminary clinical evidence, and meaningful patient-reported benefits, when delivered appropriately to the right patient population
The dosage is gradually increased over 16 to 20 weeks to mitigate gastrointestinal side effects until reaching the appropriate maximum dose
Attempting to manipulate the pen mechanism or extract medication could result in contamination, inaccurate dosing, medication waste, and potential injection site complications